UK Gives Green Light to Oxford-AstraZeneca Vaccine | Digital Trends Spanish
The United Kingdom became the first country on December 30 to approve the emergency use of the COVID-19 vaccine developed by Oxford University and the AstraZeneca laboratory.
The British government has ordered 100 million doses, which will begin to be administered from Monday, January 4, 2021 and with which it is intended to reach 50 million people.
The Secretary of Health, Matt Hancock, said that the Oxford-AstraZeneca vaccine combined with the Pfizer-BioNTech vaccine, approved in early December 2020, will allow coverage to the entire population of the country.
The measure comes at a time when the United Kingdom faces a resurgence of coronavirus infections, due to the emergence of a 70 percent more contagious strain that has forced to increase restrictions on the population.
AstraZeneca has come under pressure to develop further tests to confirm the effectiveness of its vaccine, after initial results were controversial.
During testing, the vaccine was 62 percent effective when two full doses are applied. However, it rose to 90 percent when researchers mistakenly injected an initial half dose followed by a full one.
However, the director of the Regulatory Agency for Medicines and Health Products (MHRA), June Raine, assured that “no corners have been cut” in the safety assessment.
Meanwhile, Prime Minister Boris Johnson called the development of the vaccine “a triumph” for British science. “
One of the advantages of the Oxford-Astra Zeneca vaccine is that it is easier to store and distribute as it can be kept at normal refrigerator temperature. That of Pfizer-BioNTech, meanwhile, should be kept at -70 ° C.